Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19 by Dogan Mustafa, Yilmaz Berna

Subjects: Get full text

TÜRKİYE’DE AŞI TAŞIMA SİSTEMİNDE AHP VE TOPSIS YÖNTEMLERİ İLE TAŞIMA TÜRÜ SEÇİMİ by Emel Güven, Tuğba Danışan, Zeynep Ercan, Gülşen Gümüş, Tamer Eren

Subjects: Get full text

Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages [version 1; peer review: 2 approved] by David Jeffries, Caitlin Pley, Beate Kampmann, Mam Nabou Leigh, Julia Strandmark, Ed Clarke, Peter Ndow, Ebrima Kanteh, Amadou Faal, Elishia Roberts

Subjects: Get full text

Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial by Pei Lin Hu, Eileen Yi Ling Koh, Jolene Shi Han Tay, Valerie Xin-Bei Chan, Shermin Shi Min Goh, Sinead Zhen Wang

Subjects: Get full text

Accessibility of COVID-19 Vaccines in African Countries: A System Dynamics Model Examining Income, Logistics, and Governance by Oya Öztürk, Muhammed Çelik

Subjects: Get full text

Localised swelling at sites of dermal filler injections following administration of Covid-19 vaccines: a systematic review by Chew Lip Ng, Evelyn Yuxin Tay, Alwyn Ray D’Souza

Subjects: Get full text

ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIV by Delia Pinto-Santini, Emilia M. Jalil, Giovana Teixeira Fernandes, Genevieve Hilaire, Lenka Kolevic, Robinson Cabello, Beatriz Grinsztejn, William Pape, Marie Marcelle Deschamps, Margaret G. House, Emma Brofsky, Vikrant V. Sahasrabuddhe, Sayan Dasgupta, Siavash Pasalar, Margaret M. Madeleine, Joseph Carter, Priya R. Prabhu, Denise Galloway, Ann Duerr

Subjects: Get full text

Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents by Samuel Asamoah Sakyi, Joseph Badu Gyapong, Ebenezer Krampah Aidoo, Alfred Effah, Simon Koffie, Oscar Simon Olympio Mensah, Isaac Arddey, Godwin Boakye, Stephen Opoku, Benjamin Amoani, Robert Amadu Ngala

“…WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. …”
Get full text

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination by Francesca Dapporto, Serena Marchi, Margherita Leonardi, Pietro Piu, Piero Lovreglio, Nicola Decaro, Nicola Buonvino, Angela Stufano, Eleonora Lorusso, Emilio Bombardieri, Antonella Ruello, Simonetta Viviani, Eleonora Molesti, Claudia Maria Trombetta, Alessandro Manenti, Emanuele Montomoli

“…This study aimed at investigating the avidity of receptor-binding domain (RBD) binding antibodies and their neutralizing activity against the Omicron variant in SARS-CoV-2 infected patients and vaccinees. Methods. Samples were collected from 42 SARS-CoV-2 infected patients during the first pandemic wave, 50 subjects who received 2 doses of mRNA vaccine before the Omicron wave, 44 subjects who received 3 doses of mRNA vaccine, and 35 subjects who received heterologous vaccination (2 doses of adenovirus-based vaccine plus mRNA vaccine) during the Omicron wave. …”
Get full text

AVAILABILITY AND ACCEPTABILITY OF COVID-19 VACCINE AMONG NON-TEACHING STAFF OF LAGOS STATE UNIVERSITY, OJO, LAGOS by WALIU BABATUNDE OGUNBAMOWO, OLUGBENGA ADEYEMI BODUNRIN, DANIEL OLUWATOBI ASHON, LATEEFAT ABIODUN LIGALI

Subjects: Get full text

N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine by Fernanda G. Versiani, Maria E. Almeida, Luis A. Mariuba, Patricia P. Orlandi, Paulo A. Nogueira

“…The lack of in vitro cultures for P. vivax represents a major delay in developing a functional malaria vaccine. One of the major candidates to antimalarial vaccine is the merozoite surface protein-1 (MSP1), which is expressed abundantly on the merozoite surface and capable of activating the host protective immunity. …”
Get full text

The Adoption Process to Technology Biosecurity and Vaccination in the Dispersal of Foot and Mouth Disease Bone Regency, South Sulawesi Province by Rismayanti Rismayanti

“… Adopting biosecurity and vaccination technology is one of the steps that can be taken to overcome and minimize FMD disease in beef cattle farming. …”
Get full text

Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality by Clare Bambra, Adam Todd, Fiona Matthews, David Sinclair, Natalie Bennett

“…However, more could be achieved if barriers to vaccination uptake in the most deprived areas are overcome.…”
Get full text

The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice by Chenmeng Ding, Yawei Sun, Xianfeng Zhang, Mengmeng Shi, Han Yang, Xin Zhou, Shuangshuang Li, Yongtao Li, Xia Yang, Linyang Yu, Lu Chen

“…Abstract Background Pseudorabies (PR) caused by the re-emerging of pseudorabies virus (PRV) variant has outbroken among PRV vaccine immunized swine in many pig farms, which has caused serious social and economic consequences since the end of 2011. …”
Get full text

Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity by Suleiman Al-Hammadi, Najla S. Alkuwaiti, Ghassan A. Ghatasheh, Huda Al Dhanhani, Hiba M. Shendi, Abdulghani S. Elomami, Farida Almarzooqi, Abdul-Kader Souid

“…The Bacillus Calmette–Guérin (BCG) and rotavirus vaccines are live-attenuated preparations. In the United Arab Emirates, these products are universally administered to the young infants. …”
Get full text

Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection by Ping Li, Ping Li, Ziyi Jiang, Jingjing Shi, Haochuan Sha, Zihang Yu, Yan Zhao, Sanyang Han, Lan Ma, Lan Ma, Lan Ma

Subjects: Get full text

A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2 by Ayrton Bangolo, Jeffin Cherian, Mohamed Ahmed, Ali Atoot, Bhavna Gupta, Adam Atoot

“…In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine.…”
Get full text

Vaccination ARN messager (ARNm), modèle de transition de la biologie fondamentale à la médecine by Sansonetti, Philippe J.

Subjects: Get full text

Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis by Taagbara Jolly Abaate, Dabota Yvonne Buowari, Utchay A. Agiri, Tamunodiepiriye Inimgba, Vivian Ifeoma Ogbonna, Chizaram Onyeaghala, Glory Ovunda Worgu, Abiye Somiari, Emmanuella I. Ezebuiro, Ibe Arthur Onuah

Subjects: Get full text

Association between leukocyte telomere length and specific antibody levels after vaccination against tick-borne encephalitis by N. S. Yudin, V. A. Belyavskaya, V. N. Maksimov, D. E. Ivanoshchuk, P. S. Orlov, M. I. Voevoda

Subjects: Get full text